| Financial Year |
March 31 2023 |
| Monetary Funds |
597,005,364.06 |
| Held-for-trading Financial Assets |
110,500,000.00 |
| Notes Receivable |
1,724,352.80 |
| Accounts Receivable |
105,071,319.98 |
| Advances to Suppliers |
19,426,017.24 |
| Other Receivables |
7,262,642.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
645,054,001.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,190,349.32 |
| Total Current Assets |
1,496,701,954.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
75,220,019.35 |
| Investment Properties |
10,025,443.20 |
| Fixed Assetes |
1,351,814,420.30 |
| Under-construction Projects |
173,977,352.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,315,217.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,321,068.95 |
| Deferred Income Tax Assets |
2,897,221.87 |
| Other Non-Current Assets |
319,006,802.92 |
| Sub-Total of Non-Current Assets |
2,036,577,546.31 |
| Total Assets |
3,533,279,500.61 |
| Short-Term Loans |
407,734,880.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
135,973,036.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,781,452.94 |
| Taxes Payable |
8,470,070.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,416,236.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
272,848,251.28 |
| Other Current Liabilities |
2,655,836.62 |
| Sub-Total of Current Liabilities |
931,103,416.07 |
| Long-term Loans |
290,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
319,534,694.42 |
| Total Liabilities |
1,250,638,110.49 |
| Paid-In Capital(Or Share Stock) |
905,779,387.00 |
| Capital Surplus |
630,466,559.51 |
| Surplus Reserve |
162,998,087.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
480,410,325.04 |
| Minority Stockholder's Interest |
99,408,754.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,183,232,635.56 |
| Owner's Equity（Stockholder's Equity） |
2,282,641,390.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,533,279,500.61 |
